PRICE T ROWE ASSOCIATES INC /MD/
Position in DNLI — Denali Therapeutics Inc.
CIK 80255
BALTIMORE, MD
Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$80,661,752
+$33,350,150 QoQ
Shares Held
3,136,149
+27.3% QoQ
Ownership
1.96%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#14
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. DNLI ranks #53 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $80,661,752 | 3,136,149 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $47,311,602 | 2,464,146 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $64,652,350 | 3,915,951 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $66,332,703 | 4,568,368 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $92,086,306 | 6,582,295 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $59,372,545 | 4,367,234 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $62,334,573 | 3,058,615 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $83,597,128 | 2,869,795 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $52,372,012 | 2,255,470 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $32,715,712 | 1,594,333 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $55,244,927 | 2,574,321 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $59,660,927 | 2,891,950 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $101,671,156 | 3,445,312 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $81,510,404 | 3,537,778 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $101,475,574 | 3,648,888 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $106,751,113 | 3,478,368 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $135,677,509 | 4,610,177 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $158,386,582 | 4,923,425 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $206,740,311 | 4,635,433 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $240,039,334 | 4,757,965 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $384,626,774 | 4,903,452 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $345,927,730 | 6,058,279 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $541,493,825 | 6,464,826 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $156,253,734 | 4,360,975 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $63,403,877 | 2,622,162 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $21,205,292 | 1,211,039 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||